Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Antioxid Redox Signal ; 37(4-6): 301-323, 2022 08.
Article in English | MEDLINE | ID: mdl-35081731

ABSTRACT

Significance: Reactive oxygen species (ROS) are highly reactive compounds that behave like a double-edged sword; they damage cellular structures and act as second messengers in signal transduction. Mitochondria and endoplasmic reticulum (ER) are interconnected organelles with a central role in ROS production, detoxification, and oxidative stress response. Skeletal muscle is the most abundant tissue in mammals and one of the most metabolically active ones and thus relies mainly on oxidative phosphorylation (OxPhos) to synthesize adenosine triphosphate. The impairment of OxPhos leads to myopathy and increased ROS production, thus affecting both redox poise and signaling. In addition, ROS enter the ER and trigger ER stress and its maladaptive response, which also lead to a myopathic phenotype with mitochondrial involvement. Here, we review the role of ROS signaling in myopathies due to either mitochondrial or ER dysfunction. Recent Advances: Relevant advances have been evolving over the last 10 years on the intricate ROS-dependent pathways that act as modifiers of the disease course in several myopathies. To this end, pathways related to mitochondrial biogenesis, satellite cell differentiation, and ER stress have been studied extensively in myopathies. Critical Issues: The analysis of the chemistry and the exact quantitation, as well as the localization of ROS, are still challenging due to the intrinsic labile nature of ROS and the technical limitations of their sensors. Future Directions: The mechanistic studies of the pathogenesis of mitochondrial and ER-related myopathies offer a unique possibility to discover novel ROS-dependent pathways. Antioxid. Redox Signal. 37, 301-323.


Subject(s)
Endoplasmic Reticulum Stress , Muscular Diseases , Animals , Endoplasmic Reticulum/metabolism , Mammals/metabolism , Muscular Diseases/genetics , Muscular Diseases/metabolism , Oxidation-Reduction , Oxidative Stress , Reactive Oxygen Species/metabolism , Signal Transduction
2.
EMBO Mol Med ; 10(11)2018 11.
Article in English | MEDLINE | ID: mdl-30309855

ABSTRACT

The mTOR inhibitor rapamycin ameliorates the clinical and biochemical phenotype of mouse, worm, and cellular models of mitochondrial disease, via an unclear mechanism. Here, we show that prolonged rapamycin treatment improved motor endurance, corrected morphological abnormalities of muscle, and increased cytochrome c oxidase (COX) activity of a muscle-specific Cox15 knockout mouse (Cox15sm/sm ). Rapamycin treatment restored autophagic flux, which was impaired in naïve Cox15sm/sm muscle, and reduced the number of damaged mitochondria, which accumulated in untreated Cox15sm/sm mice. Conversely, rilmenidine, an mTORC1-independent autophagy inducer, was ineffective on the myopathic features of Cox15sm/sm animals. This stark difference supports the idea that inhibition of mTORC1 by rapamycin has a key role in the improvement of the mitochondrial function in Cox15sm/sm muscle. In contrast to rilmenidine, rapamycin treatment also activated lysosomal biogenesis in muscle. This effect was associated with increased nuclear localization of TFEB, a master regulator of lysosomal biogenesis, which is inhibited by mTORC1-dependent phosphorylation. We propose that the coordinated activation of autophagic flux and lysosomal biogenesis contribute to the effective clearance of dysfunctional mitochondria by rapamycin.


Subject(s)
Autophagy , Lysosomes/metabolism , Mitochondrial Myopathies/pathology , Organelle Biogenesis , Sirolimus/pharmacology , Animals , Autophagy/drug effects , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Electron Transport Complex IV/metabolism , Lysosomes/drug effects , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/ultrastructure , Mitochondrial Myopathies/metabolism , Motor Activity/drug effects , Muscles/drug effects , Muscles/pathology , Phenotype , Rilmenidine/pharmacology , TOR Serine-Threonine Kinases/metabolism
3.
Cell Metab ; 28(5): 764-775.e5, 2018 11 06.
Article in English | MEDLINE | ID: mdl-30122554

ABSTRACT

Alternative oxidases (AOXs) bypass respiratory complexes III and IV by transferring electrons from coenzyme Q directly to O2. They have therefore been proposed as a potential therapeutic tool for mitochondrial diseases. We crossed the severely myopathic skeletal muscle-specific COX15 knockout (KO) mouse with an AOX-transgenic mouse. Surprisingly, the double KO-AOX mutants had decreased lifespan and a substantial worsening of the myopathy compared with KO alone. Decreased ROS production in KO-AOX versus KO mice led to impaired AMPK/PGC-1α signaling and PAX7/MYOD-dependent muscle regeneration, blunting compensatory responses. Importantly, the antioxidant N-acetylcysteine had a similar effect, decreasing the lifespan of KO mice. Our findings have major implications for understanding pathogenic mechanisms in mitochondrial diseases and for the design of therapies, highlighting the benefits of ROS signaling and the potential hazards of antioxidant treatment.


Subject(s)
Mitochondrial Myopathies/metabolism , Mitochondrial Proteins/metabolism , Oxidoreductases/metabolism , Plant Proteins/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction , Animals , Autophagy , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondrial Myopathies/genetics , Mitochondrial Myopathies/pathology , Mitochondrial Proteins/genetics , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Organelle Biogenesis , Oxidation-Reduction , Oxidoreductases/genetics , Plant Proteins/genetics
4.
Hum Mol Genet ; 26(21): 4181-4189, 2017 11 01.
Article in English | MEDLINE | ID: mdl-28985337

ABSTRACT

Although mitochondria are ubiquitous, each mitochondrial disease has surprisingly distinctly different pattern of tissue and organ involvement. Congruently, mutations in genes encoding for different mitochondrial tRNA synthetases result in the development of a very flamboyant group of diseases. Mutations in some of these genes, including aspartyl-tRNA synthetase (DARS2), lead to the onset of a white matter disease-leukoencephalopathy with brainstem and spinal cord involvement, and lactate elevation (LBSL) characterized by progressive spastic ataxia and characteristic leukoencephalopathy signature with multiple long-tract involvements. Puzzled by the white matter disease phenotypes caused by DARS2 deficiency when numerous other mutations in the genes encoding proteins involved in mitochondrial translation have a detrimental effect predominantly on neurons, we generated transgenic mice in which DARS2 was specifically depleted in forebrain-hippocampal neurons or myelin-producing cells. Our results now provide the first evidence that loss of DARS2 in adult neurons leads to strong mitochondrial dysfunction and progressive loss of cells. In contrast, myelin-producing cells seem to be resistant to cell death induced by DARS2 depletion despite robust respiratory chain deficiency arguing that LBSL might originate from the primary neuronal and axonal defect. Remarkably, our results also suggest a role for early neuroinflammation in the disease progression, highlighting the possibility for therapeutic interventions of this process.


Subject(s)
Aspartate-tRNA Ligase/deficiency , Myelin Sheath/metabolism , Neurons/metabolism , Animals , Apoptosis , Aspartate-tRNA Ligase/genetics , Aspartate-tRNA Ligase/metabolism , Brain Stem/metabolism , Disease Models, Animal , Leukoencephalopathies/genetics , Leukoencephalopathies/metabolism , Mice , Mice, Transgenic , Mitochondria/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Diseases/metabolism , Nervous System Malformations/metabolism , Spinal Cord/metabolism , Spinocerebellar Degenerations/metabolism
5.
Mol Cell ; 67(1): 96-105.e4, 2017 Jul 06.
Article in English | MEDLINE | ID: mdl-28673544

ABSTRACT

Loss-of-function mutations in TTC19 (tetra-tricopeptide repeat domain 19) have been associated with severe neurological phenotypes and mitochondrial respiratory chain complex III deficiency. We previously demonstrated the mitochondrial localization of TTC19 and its link with complex III biogenesis. Here we provide detailed insight into the mechanistic role of TTC19, by investigating a Ttc19?/? mouse model that shows progressive neurological and metabolic decline, decreased complex III activity, and increased production of reactive oxygen species. By using both the Ttc19?/? mouse model and a range of human cell lines, we demonstrate that TTC19 binds to the fully assembled complex III dimer, i.e., after the incorporation of the iron-sulfur Rieske protein (UQCRFS1). The in situ maturation of UQCRFS1 produces N-terminal polypeptides, which remain bound to holocomplex III. We show that, in normal conditions, these UQCRFS1 fragments are rapidly removed, but when TTC19 is absent they accumulate within complex III, causing its structural and functional impairment.


Subject(s)
Electron Transport Complex III/metabolism , Iron-Sulfur Proteins/metabolism , Membrane Proteins/metabolism , Mitochondria/enzymology , Mitochondrial Proteins/metabolism , Animals , Behavior, Animal , Disease Models, Animal , Electron Transport Complex III/deficiency , Electron Transport Complex III/genetics , Female , Genotype , HeLa Cells , Humans , Iron-Sulfur Proteins/genetics , Kinetics , Male , Membrane Proteins/genetics , Mice, Inbred C57BL , Mice, Knockout , Mitochondrial Diseases , Mitochondrial Proteins/genetics , Motor Activity , Nerve Degeneration , Nervous System/metabolism , Nervous System/pathology , Nervous System/physiopathology , Phenotype , Protein Binding , Protein Stability , Proteolysis , Reactive Oxygen Species/metabolism
6.
PLoS Genet ; 10(6): e1004385, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24945157

ABSTRACT

Although mitochondrial dysfunction is often accompanied by excessive reactive oxygen species (ROS) production, we previously showed that an increase in random somatic mtDNA mutations does not result in increased oxidative stress. Normal levels of ROS and oxidative stress could also be a result of an active compensatory mechanism such as a mild increase in proton leak. Uncoupling protein 2 (UCP2) was proposed to play such a role in many physiological situations. However, we show that upregulation of UCP2 in mtDNA mutator mice is not associated with altered proton leak kinetics or ROS production, challenging the current view on the role of UCP2 in energy metabolism. Instead, our results argue that high UCP2 levels allow better utilization of fatty acid oxidation resulting in a beneficial effect on mitochondrial function in heart, postponing systemic lactic acidosis and resulting in longer lifespan in these mice. This study proposes a novel mechanism for an adaptive response to mitochondrial cardiomyopathy that links changes in metabolism to amelioration of respiratory chain deficiency and longer lifespan.


Subject(s)
Energy Metabolism/genetics , Fatty Acids/metabolism , Ion Channels/genetics , Mitochondria, Heart/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Proteins/genetics , Acidosis, Lactic/metabolism , Animals , Cardiomyopathies/pathology , Eating/genetics , Life Expectancy , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria, Heart/genetics , Mitochondrial Diseases/metabolism , Myocardium/metabolism , Oxidation-Reduction , Oxidative Stress , Proton Pumps/genetics , Reactive Oxygen Species/metabolism , Uncoupling Protein 2
7.
Cell Metab ; 19(3): 458-69, 2014 Mar 04.
Article in English | MEDLINE | ID: mdl-24606902

ABSTRACT

Adaptive stress responses activated upon mitochondrial dysfunction are assumed to arise in order to counteract respiratory chain deficiency. Here, we demonstrate that loss of DARS2 (mitochondrial aspartyl-tRNA synthetase) leads to the activation of various stress responses in a tissue-specific manner independently of respiratory chain deficiency. DARS2 depletion in heart and skeletal muscle leads to the severe deregulation of mitochondrial protein synthesis followed by a strong respiratory chain deficit in both tissues, yet the activation of adaptive responses is observed predominantly in cardiomyocytes. We show that the impairment of mitochondrial proteostasis in the heart activates the expression of mitokine FGF21, which acts as a signal for cell-autonomous and systemic metabolic changes. Conversely, skeletal muscle has an intrinsic mechanism relying on the slow turnover of mitochondrial transcripts and higher proteostatic buffering capacity. Our results show that mitochondrial dysfunction is sensed independently of respiratory chain deficiency, questioning the current view on the role of stress responses in mitochondrial diseases.


Subject(s)
Aspartate-tRNA Ligase/metabolism , Muscle, Skeletal/metabolism , Myocardium/metabolism , Animals , Aspartate-tRNA Ligase/deficiency , Aspartate-tRNA Ligase/genetics , Cell Line , Embryonic Development , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/metabolism , Genotype , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondrial Diseases/metabolism , Mitochondrial Diseases/pathology , Mitochondrial Proteins/biosynthesis , Muscle, Skeletal/pathology , Myocardium/pathology , Phenotype , Transfer RNA Aminoacylation
8.
PLoS One ; 8(12): e81952, 2013.
Article in English | MEDLINE | ID: mdl-24349158

ABSTRACT

In the present study, to contribute to the understanding of the evolutionary history of sheep, the mitochondrial (mt) DNA polymorphisms occurring in modern Turkish native domestic (n = 628), modern wild (Ovis gmelinii anatolica) (n = 30) and ancient domestic sheep from Oylum Höyük in Kilis (n = 33) were examined comparatively with the accumulated data in the literature. The lengths (75 bp/76 bp) of the second and subsequent repeat units of the mtDNA control region (CR) sequences differentiated the five haplogroups (HPGs) observed in the domestic sheep into two genetic clusters as was already implied by other mtDNA markers: the first cluster being composed of HPGs A, B, D and the second cluster harboring HPGs C, E. To manifest genetic relatedness between wild Ovis gmelinii and domestic sheep haplogroups, their partial cytochrome B sequences were examined together on a median-joining network. The two parallel but wider aforementioned clusters were observed also on the network of Ovis gmelenii individuals, within which domestic haplogroups were embedded. The Ovis gmelinii wilds of the present day appeared to be distributed on two partially overlapping geographic areas parallel to the genetic clusters that they belong to (the first cluster being in the western part of the overall distribution). Thus, the analyses suggested that the domestic sheep may be the products of two maternally distinct ancestral Ovis gmelinii populations. Furthermore, Ovis gmelinii anatolica individuals exhibited a haplotype of HPG A (n = 22) and another haplotype (n = 8) from the second cluster which was not observed among the modern domestic sheep. HPG E, with the newly observed members (n = 11), showed signs of expansion. Studies of ancient and modern mtDNA suggest that HPG C frequency increased in the Southeast Anatolia from 6% to 22% some time after the beginning of the Hellenistic period, 500 years Before Common Era (BCE).


Subject(s)
Biological Evolution , Cytochromes b/classification , DNA, Mitochondrial/classification , Phylogeny , Sheep, Domestic/classification , Sheep/classification , Animals , Cytochromes b/genetics , DNA, Mitochondrial/genetics , Female , Haplotypes , Humans , Male , Mitochondria/genetics , Multigene Family , Phylogeography , Polymorphism, Genetic , Sheep/genetics , Sheep, Domestic/genetics , Turkey
SELECTION OF CITATIONS
SEARCH DETAIL
...